Leebeek FW - Search Results

1

High von Willebrand factor levels increase the risk of stroke: the Rotterdam study.

Wieberdink RG, van Schie MC, Koudstaal PJ, Hofman A, Witteman JC, de Maat MP, Leebeek FW, Breteler MM. Wieberdink RG, et al. Among authors: leebeek fw. Stroke. 2010 Oct;41(10):2151-6. doi: 10.1161/STROKEAHA.110.586289. Epub 2010 Aug 26. Stroke. 2010. PMID: 20798373

2

PLA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIa in young patients with cryptogenic TIA or ischemic stroke.

van Goor ML, Gómez García E, Brouwers GJ, Leebeek FW, Koudstaal PJ, Dippel DW. van Goor ML, et al. Among authors: leebeek fw. Thromb Res. 2002 Oct 1;108(1):63-5. doi: 10.1016/s0049-3848(02)00356-0. Thromb Res. 2002. PMID: 12586134

3

Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.

Brouwers GJ, Leebeek FW, Tanck MW, Wouter Jukema J, Kluft C, de Maat MP. Brouwers GJ, et al. Among authors: leebeek fw. Thromb Haemost. 2003 Jul;90(1):92-100. Thromb Haemost. 2003. PMID: 12876631

4

Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study.

van der Meer IM, Brouwers GJ, Bulk S, Leebeek FW, van der Kuip DA, Hofman A, Witteman JC, Gómez García EB. van der Meer IM, et al. Among authors: leebeek fw. Br J Haematol. 2004 Feb;124(3):343-7. doi: 10.1046/j.1365-2141.2003.04776.x. Br J Haematol. 2004. PMID: 14717782 Free article.

5

What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke?

Dippel DW, Van Kooten F, Leebeek FW, van Vliet HH, Mehicevic A, Li SS, Koudstaal PJ. Dippel DW, et al. Among authors: leebeek fw. Cerebrovasc Dis. 2004;17(4):296-302. doi: 10.1159/000077340. Epub 2004 Mar 15. Cerebrovasc Dis. 2004. PMID: 15026612 Clinical Trial.

6

In vitro studies, pharmacokinetic studies and clinical use of a high purity double virus inactivated FVIII/VWF concentrate (Immunate) in the treatment of von Willebrand disease.

Ver Elst KM, van Vliet HD, Kappers-Klunne MC, Leebeek FW. Ver Elst KM, et al. Among authors: leebeek fw. Thromb Haemost. 2004 Jul;92(1):67-74. doi: 10.1160/TH04-02-0107. Thromb Haemost. 2004. PMID: 15213847

7

Genetic variability of von Willebrand factor and atherosclerosis.

Leebeek FW, van der Meer IM, Witteman JC. Leebeek FW, et al. Circulation. 2004 Aug 3;110(5):e57. doi: 10.1161/01.cir.0000141263.99616.d9. Circulation. 2004. PMID: 15289398 No abstract available.

8

The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.

van Goor ML, Gómez García E, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D. van Goor ML, et al. Thromb Haemost. 2005 Jan;93(1):92-6. doi: 10.1160/TH04-09-0560. Thromb Haemost. 2005. PMID: 15630497

9

Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.

Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Lisman T, et al. Among authors: leebeek fw. Hepatology. 2006 Jul;44(1):53-61. doi: 10.1002/hep.21231. Hepatology. 2006. PMID: 16799972

10

High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability.

Bongers TN, de Maat MP, van Goor ML, Bhagwanbali V, van Vliet HH, Gómez García EB, Dippel DW, Leebeek FW. Bongers TN, et al. Among authors: leebeek fw. Stroke. 2006 Nov;37(11):2672-7. doi: 10.1161/01.STR.0000244767.39962.f7. Epub 2006 Sep 21. Stroke. 2006. PMID: 16990571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters